Abstract
Clostridium difficile, a Gram-positive, spore-forming, anaerobic bacterium, is the main causative agent of hospital-acquired diarrhoea worldwide. In addition to metronidazole and vancomycin, rifaximin, a rifamycin derivative, is a promising antibiotic for the treatment of recurring C. difficile infections (CDI). However, exposure of C. difficile to this antibiotic has led to the development of rifaximin-resistance due to point mutations in the β-subunit of the RNA polymerase (rpoB) gene. In the present study, 348 C. difficile strains with known PCR-ribotypes were investigated for respective single nucleotide polymorphisms (SNPs) within the proposed rpoB hot-spot region by using high-resolution melting (HRM) analysis. This method allows the detection of SNPs by comparing the altered melting behaviour of dsDNA with that of wild-type DNA. Discrimination between wild-type and mutant strains was enhanced by creating heteroduplexes by mixing sample DNA with wild-type DNA, leading to characteristic melting curve shapes from samples containing SNPs in the respective rpoB section. In the present study, we were able to identify 16 different rpoB sequence-types (ST) by sequencing analysis of a 325 bp fragment. The 16 PCR STs displayed a t...Continue Reading
References
Jan 11, 2001·The Journal of Antimicrobial Chemotherapy·J WiströmB Svenungsson
Apr 6, 2001·Cell·E A CampbellS A Darst
May 27, 2003·Clinical Chemistry·Carl T WittwerRobert J Pryor
Jul 2, 2004·Clinical Chemistry·Michael LiewCarl Wittwer
Jan 10, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Robert Sackstein
Feb 8, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H Humphreys, E T M Smyth
Sep 13, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E J KuijperUNKNOWN European Centre for Disease Prevention and Control
Feb 17, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stuart JohnsonDale N Gerding
May 16, 2008·Journal of Medical Microbiology·A IndraF Allerberger
Jun 19, 2008·Antimicrobial Agents and Chemotherapy·Jennifer R O'ConnorStuart Johnson
Jan 15, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Scott R CurryLee H Harrison
Sep 21, 2010·Anaerobe·Haihui HuangCarl Erik Nord
Feb 5, 2011·Journal of Medical Microbiology·Steliana HuhulescuAlexander Indra
Aug 26, 2011·Nature·Ankur MutrejaGordon Dougan
Oct 15, 2011·Journal of Clinical Microbiology·Mark A MillerPaola Mastrantonio
Citations
Oct 31, 2015·Journal of Medical Microbiology·Stephanie L AngioneAnubhav Tripathi
Mar 25, 2015·Microbiological Research·Ranjan KoiralaSimone Guglielmetti
Jul 23, 2016·Genome Announcements·François WaselsPatrizia Spigaglia
Feb 11, 2016·Therapeutic Advances in Infectious Disease·Patrizia Spigaglia
Jun 1, 2018·Annals of Saudi Medicine·Hani Adnan Ozbak
Jul 7, 2016·Antimicrobial Agents and Chemotherapy·Uyen T DangJulian G Hurdle
Mar 17, 2019·Parasitology Research·Ellen SchoenerHans-Peter Fuehrer
Jun 21, 2018·Medicine·Baoya WangJianrong Su
Mar 14, 2019·MBio·Kate E DingleDerrick W Crook
Feb 3, 2018·Microbes and Infection·Larry K KociolekEgon A Ozer
Jan 24, 2020·Microbiology Spectrum·Marie Archambault, Joseph E Rubin
Jul 29, 2021·Journal of Global Antimicrobial Resistance·Dokyun KimHeejung Kim
Aug 25, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Keeley O'GradyThomas V Riley